Global Bioinformatics Services Market By Type (Chemi-Informatics, NGS, Scientific Software Testing, Micro Array Data Analysis, and Other Types), By Application (Genomics, Metabolomics, Transcriptomic, Drug discovery, and Proteomics), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Report Overview

Global Bioinformatics Services’ market value was US$ 2,641 million in 2021, experiencing a CAGR of 15.19%.

The growth of genomics-oriented R&D and the growing use of the technology in drug discovery, biomarker development, and drug discovery are expected to drive this industry. This industry is expected to see significant progress due to a gradual decrease in the costs of DNA sequencing.

Global Bioinformatics Services Market

Type Analysis

NGS can be described as targeted sequencing, transcriptome analysis, whole-genome sequencing, chipset, and de-novo assembly. NGS captured over 41% market share in 2021 due to its increased adoption due to a lower-cost sequencer and growing use of sequencing technology in enabling quicker R&D fields such as biomarker development, precision medicine, and disease prediction.

Chemoinformatics is expected to experience the highest growth due to upcoming advances in high-performance computing and molecular modeling.

Application Analysis

The sector can be segmented by Bioinformatics Services applications in genome, transcriptomic, and proteomics, as well as drug discovery. The industry is expected to see a rise in demand over the forecast period due to the rising demand for personalized healthcare, real-time disease management, and preventive medicine. Furthermore, transcriptomics is expected to grow faster due to increased research projects and technological advancements in the field.

Key Market Segments

By Type

• Chemi-Informatics
• NGS
• Scientific Software Testing
• Micro Array Data Analysis
• Other Types

By Application

• Genomics
• Metabolomics
• Transcriptomic
• Drug discovery
• Proteomics

Market Dynamics

The demand for integrated solutions for managing large quantities of data generated by high throughput sequencing and related technologies has positioned the market for Bioinformatics Services to offer high-value avenues for growth.

To increase the demand for I.T., it is anticipated that there will be an increase in R&D investment in metabolomics and transcriptomics. Data storage and analysis capabilities, as well as applications. Genomics and proteomics deal with large quantities of structural information. This information needs to be sorted and processed to extract useful information. This technology allows for easy storage and management of large amounts of data, increasing usage.

Factors such as the development of ICT infrastructure or relocation of data service routing via cloud computing and employing a third person to maintain it will be driving R&D to meet emerging demand.

This industry is expected to be hindered by factors like a shortage of skilled personnel using Bioinformatics Services software and a lack of data integration. This industry will present challenges to manufacturers and providers of these solutions & services, including high volume statistics management and industry consolidation.

Regional Analysis

North America held a dominant position in the region industry, accounting for 31.23% in 2021. A well-established regulatory framework facilitates the industry’s participation. This subsequently results in the generation of industrial revenues. The highest impact factor driving the increased penetration of drug-discovery-based informatics services is the simultaneous development and maintenance of chemical laboratories in the region.

The Asia Pacific is expected to experience the fastest growth in Bioinformatics Services, with a two-digit expected growth rate from 2023-2032. This growth can be attributed to improvements in healthcare infrastructure and initiatives by pharmaceutical companies operating within this region. The Asia Pacific is home to many people suffering from infectious diseases. This will drive sector growth. The area is home to 60% of the world’s population. This means that even low levels of infection can lead to large numbers. Australia and India are two emerging economies contributing to the region’s revenue share and growth. As outsourcing services gain momentum, a growing number of Asian countries build the infrastructure that is expected to influence revenue generation in this industry through the virtue of government investment and academic innovation.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

Several major players are involved in strategic collaborations and partnerships with various information technology companies to improve their customer base by offering enhanced information management solutions. CTC Life Science Corporation partnered with GVK Bio in November 2014. This partnership is expected to strengthen the relations between the firms and increase GVK’s market visibility by enabling the marketing of clinical data management products, such as GVK Bio’s GOSTAR & GOBIOM. It also allows for custom curation services.

Маrkеt Кеу Рlауеrѕ:

• Accelerys Inc.
• Qiagen Inc.
• GVK Biosciences
• Illumina Inc.
• Agilent Technologies
• Life Technologies Corp.
• Celera Corp.
• IBM Life sciences
• Other Key Players

For the Bioinformatics Services Market research study, the following years have been considered to estimate the market size: